Hologic Q1 Revenues Grow 7 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Hologic reported after the close of the market Wednesday that revenues for its fiscal first quarter were up about 7 percent year over year driven in part by growth in its diagnostics and molecular diagnostics businesses. 

The Bedford, Massachusetts-based firm reported total revenues of $695.2 million for the quarter ended Dec. 26, up from $652.8 million in the prior year and above the Wall Street estimate of $688 million. On a constant currency basis, Q1 revenues grew 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.